Table II.
Study | Truly random | Random allocation | Equivalence of baseline features | Eligibility criteria | Blinding assessment | Loss to follow-up | Intent to treat | Study quality |
---|---|---|---|---|---|---|---|---|
Herbst et al (21) | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | High |
Gatzemeier et al (20) | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | High |
Mok et al (30) | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | High |
Cappuzzo et al (16) | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | High |
Perol et al (32) | Yes | No | Yes | Yes | Yes | Unclear | Yes | Fair |
Kabbinavar et al (31) | Yes | Yes | Yes | Yes | Unclear | Unclear | Yes | Fair |